Impact of Protease Inhibitor‐Containing Blood Collection Tubes on Targeted Proteomic Profiles of Alzheimer's Disease Plasma Biomarkers

Abstract

Background: Blood‐based biomarkers (BBMs) are promising for diagnosing Alzheimer's disease (AD). However, a significant challenge related to specimen quality is anticipated as BBMs are integrated into real‐world settings, where access to specialized equipment may be limited.

The paper